STAT3- and DNA Methyltransferase 1-Mediated Epigenetic Silencing of SHP-1 Tyrosine Phosphatase Tumor Suppressor Gene in Malignant T Lymphocytes
Expression of SHP-1 phosphatase, a key negative regulator of cell signaling, is lost in T cell lymphomas and other malignancies due to DNA methylation of the SHP-1 promoter by a currently undefined mechanism. We demonstrate that malignant T cells express DNA methyltransferase (DNMT) 1 and that const...
Saved in:
Published in | Proceedings of the National Academy of Sciences - PNAS Vol. 102; no. 19; pp. 6948 - 6953 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
National Academy of Sciences
10.05.2005
National Acad Sciences |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Expression of SHP-1 phosphatase, a key negative regulator of cell signaling, is lost in T cell lymphomas and other malignancies due to DNA methylation of the SHP-1 promoter by a currently undefined mechanism. We demonstrate that malignant T cells express DNA methyltransferase (DNMT) 1 and that constantly activated signal transducer and activator of transcription (STAT) 3 is capable of binding in vitro to DNA oligonucleotides corresponding to four STAT3 SIE/GAS binding sites identified in the SHP-1 promoter. STAT3, DNMT1, and histone deacetylase 1 form complexes and bind to the SHP-1 promoter in vivo. Treatment with pharmacologic grade DNMT1 anti-sense oligonucleotides and STAT3 small-interfering RNA induces in the malignant T cells DNA demethylation and expression of SHP-1 gene. These data indicate that STAT3 may, in part, transform cells by inducing epigenetic silencing of SHP-1 in cooperation with DNMT1 and, apparently, histone deacetylase 1. Reversal of such gene silencing represents an attractive aim for novel anticancer therapies. |
---|---|
AbstractList | Expression of SHP-1 phosphatase, a key negative regulator of cell signaling, is lost in T cell lymphomas and other malignancies due to DNA methylation of the SHP-1 promoter by a currently undefined mechanism. We demonstrate that malignant T cells express DNA methyltransferase (DNMT) 1 and that constantly activated signal transducer and activator of transcription (STAT) 3 is capable of binding in vitro to DNA oligonucleotides corresponding to four STAT3 SIE/GAS binding sites identified in the SHP-1 promoter. STAT3, DNMT1, and histone deacetylase 1 form complexes and bind to the SHP-1 promoter in vivo. Treatment with pharmacologic grade DNMT1 anti-sense oligonucleotides and STAT3 small-interfering RNA induces in the malignant T cells DNA demethylation and expression of SHP-1 gene. These data indicate that STAT3 may, in part, transform cells by inducing epigenetic silencing of SHP-1 in cooperation with DNMT1 and, apparently, histone deacetylase 1. Reversal of such gene silencing represents an attractive aim for novel anticancer therapies. Expression of SHP-1 phosphatase, a key negative regulator of cell signaling, is lost in T cell lymphomas and other malignancies due to DNA methylation of the SHP-1 promoter by a currently undefined mechanism. We demonstrate that malignant T cells express DNA methyltransferase (DNMT) 1 and that constantly activated signal transducer and activator of transcription (STAT) 3 is capable of binding in vitro to DNA oligonucleotides corresponding to four STAT3 SIE/GAS binding sites identified in the SHP-1 promoter. STAT3, DNMT1, and histone deacetylase 1 form complexes and bind to the SHP-1 promoter in vivo . Treatment with pharmacologic grade DNMT1 anti-sense oligonucleotides and STAT3 small-interfering RNA induces in the malignant T cells DNA demethylation and expression of SHP-1 gene. These data indicate that STAT3 may, in part, transform cells by inducing epigenetic silencing of SHP-1 in cooperation with DNMT1 and, apparently, histone deacetylase 1. Reversal of such gene silencing represents an attractive aim for novel anticancer therapies. Expression of SHP-1 phosphatase, a key negative regulator of cell signaling, is lost in T cell lymphomas and other malignancies due to DNA methylation of the SHP-1 promoter by a currently undefined mechanism. We demonstrate that malignant T cells express DNA methyltransferase (DNMT) 1 and that constantly activated signal transducer and activator of transcription (STAT) 3 is capable of binding in vitro to DNA oligonucleotides corresponding to four STAT3 SIE/GAS binding sites identified in the SHP-1 promoter. STAT3, DNMT1, and histone deacetylase 1 form complexes and bind to the SHP-1 promoter in vivo . Treatment with pharmacologic grade DNMT1 anti-sense oligonucleotides and STAT3 small-interfering RNA induces in the malignant T cells DNA demethylation and expression of SHP-1 gene. These data indicate that STAT3 may, in part, transform cells by inducing epigenetic silencing of SHP-1 in cooperation with DNMT1 and, apparently, histone deacetylase 1. Reversal of such gene silencing represents an attractive aim for novel anticancer therapies. DNMT1 SHP-1 STAT3 Expression of SHP-1 phosphatase, a key negative regulator of cell signaling, is lost in T cell lymphomas and other malignancies due to DNA methylation of the SHP-1 promoter by a currently undefined mechanism. We demonstrate that malignant T cells express DNA methyltransferase (DNMT) 1 and that constantly activated signal transducer and activator of transcription (STAT) 3 is capable of binding in vitro to DNA oligonucleotides corresponding to four STAT3 SIE/GAS binding sites identified in the SHP-1 promoter. STAT3, DNMT1, and histone deacetylase 1 form complexes and bind to the SHP-1 promoter in vivo. Treatment with pharmacologic grade DNMT1 anti-sense oligonucleotides and STAT3 small-interfering RNA induces in the malignant T cells DNA demethylation and expression of SHP-1 gene. These data indicate that STAT3 may, in part, transform cells by inducing epigenetic silencing of SHP-1 in cooperation with DNMT1 and, apparently, histone deacetylase 1. Reversal of such gene silencing represents an attractive aim for novel anticancer therapies. [PUBLICATION ABSTRACT] |
Author | Marzec, Michal Nowell, Peter C. Wang, Hong Y. Zhang, Qian Nagasawa, Tomohiko Wasik, Mariusz A. Raghunath, Puthiyaveettil N. |
AuthorAffiliation | Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA 19104 |
AuthorAffiliation_xml | – name: Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA 19104 |
Author_xml | – sequence: 1 givenname: Qian surname: Zhang fullname: Zhang, Qian – sequence: 2 givenname: Hong Y. surname: Wang fullname: Wang, Hong Y. – sequence: 3 givenname: Michal surname: Marzec fullname: Marzec, Michal – sequence: 4 givenname: Puthiyaveettil N. surname: Raghunath fullname: Raghunath, Puthiyaveettil N. – sequence: 5 givenname: Tomohiko surname: Nagasawa fullname: Nagasawa, Tomohiko – sequence: 6 givenname: Mariusz A. surname: Wasik fullname: Wasik, Mariusz A. – sequence: 7 givenname: Peter C. surname: Nowell fullname: Nowell, Peter C. |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/15870198$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkk9v0zAYxi00xLrCmQsCiwPiks3_EscXpGqMDamFSQ1ny0mc1lVqZ7GDyKfgK-Oo1Qoc4GRL_j2P3_fRcwHOrLMagJcYXWLE6VVnlb9EKcIiFRiRJ2CGkcBJxgQ6AzOECE9yRtg5uPB-hxASaY6egXOc5jxq8hn4uS4WBU2gsjX8-GUBVzpsxzb0yvpG98priJOVro0KuoY3ndloq4Op4Nq02lbGbqBr4PruPsGwGHvnjdXwfut8t1VhUhfD3vVwPXRdr72P19toAI2FK9WajVU2wAIux323ddUYtH8Onjaq9frF8ZyDb59uiuu7ZPn19vP1YplUKeEhESXFNWO4VmWGMsHShog6S_MqE7zJCRaIlpRkGDFNy5rULC1rjCvFOUOM5ojOwYeDbzeUe11X2sadW9n1Zq_6UTpl5J8v1mzlxn2XGCPEcxoN3h0NevcwaB_k3vhKt62y2g1eZjyOwQj-L4h5RgiJlnPw9i9w54bexhQkQZhyIfj07dUBqmLYvtfN48gYyakScqqEPFUiKl7_vumJP3YgAm-OwKQ82RGJhYzZTsT7fxOyGdo26B8hoq8O6M4H1z-ylPKUZZj-AuzI1UI |
CitedBy_id | crossref_primary_10_1073_pnas_1205132109 crossref_primary_10_4049_jimmunol_1100573 crossref_primary_10_1038_nrm2039 crossref_primary_10_1186_1476_4598_12_50 crossref_primary_10_1016_j_cell_2014_07_031 crossref_primary_10_1038_s41419_020_02934_8 crossref_primary_10_1016_j_smim_2006_03_013 crossref_primary_10_2174_1568009622666220301105214 crossref_primary_10_1146_annurev_immunol_26_021607_090418 crossref_primary_10_1155_2015_178698 crossref_primary_10_3390_ijms20092256 crossref_primary_10_1016_j_it_2023_09_005 crossref_primary_10_1189_jlb_0312126 crossref_primary_10_3390_biom9120875 crossref_primary_10_1186_s13148_020_00962_x crossref_primary_10_1007_s10620_012_2152_1 crossref_primary_10_1016_j_neuron_2007_04_019 crossref_primary_10_5858_2010_0507_RAR_1 crossref_primary_10_1002_jcb_20838 crossref_primary_10_1111_imr_12172 crossref_primary_10_1186_s13148_018_0450_y crossref_primary_10_4049_jimmunol_180_9_5898 crossref_primary_10_1038_nri2958 crossref_primary_10_1111_bjh_15763 crossref_primary_10_3390_cancers12103037 crossref_primary_10_4049_jimmunol_2000234 crossref_primary_10_1007_s11864_024_01202_7 crossref_primary_10_1016_j_jgg_2020_04_006 crossref_primary_10_3389_fimmu_2018_01886 crossref_primary_10_1161_JAHA_117_007572 crossref_primary_10_1152_ajpheart_00570_2012 crossref_primary_10_1016_j_ygyno_2006_10_003 crossref_primary_10_1038_s41375_023_02038_0 crossref_primary_10_1158_0008_5472_CAN_18_0359 crossref_primary_10_1016_j_biochi_2012_05_029 crossref_primary_10_1158_0008_5472_CAN_19_3670 crossref_primary_10_3389_fonc_2022_835290 crossref_primary_10_1016_j_dci_2008_10_006 crossref_primary_10_1038_s41375_018_0117_x crossref_primary_10_1016_j_kint_2024_04_017 crossref_primary_10_1189_jlb_0608383 crossref_primary_10_1186_s12943_017_0736_2 crossref_primary_10_1038_s41419_021_04470_5 crossref_primary_10_1159_000353893 crossref_primary_10_1016_j_biocel_2021_106118 crossref_primary_10_1038_onc_2011_308 crossref_primary_10_1158_0008_5472_CAN_10_3304 crossref_primary_10_4049_jimmunol_0803721 crossref_primary_10_1371_journal_pone_0090275 crossref_primary_10_3389_fonc_2020_00612 crossref_primary_10_3724_SP_J_1206_2011_00196 crossref_primary_10_3389_fphys_2019_00500 crossref_primary_10_1007_s00262_020_02620_w crossref_primary_10_1016_j_leukres_2007_11_035 crossref_primary_10_1111_j_1365_2559_2009_03290_x crossref_primary_10_1155_2012_123253 crossref_primary_10_1038_s41375_021_01296_0 crossref_primary_10_1016_j_celrep_2016_09_018 crossref_primary_10_1002_cncr_26736 crossref_primary_10_1038_leu_2011_198 crossref_primary_10_1152_ajpregu_00632_2009 crossref_primary_10_1038_s41467_018_02890_0 crossref_primary_10_3390_genes11111336 crossref_primary_10_1371_journal_pone_0250499 crossref_primary_10_1053_j_seminoncol_2009_02_007 crossref_primary_10_3390_cells9010217 crossref_primary_10_1002_stem_470 crossref_primary_10_1002_hed_21586 crossref_primary_10_1016_j_semcdb_2016_02_009 crossref_primary_10_1007_s13277_013_1590_5 crossref_primary_10_1210_en_2006_0288 crossref_primary_10_1021_jm4018042 crossref_primary_10_1042_BST20150251 crossref_primary_10_3389_fphar_2020_01099 crossref_primary_10_1111_j_1365_2141_2006_06206_x crossref_primary_10_3390_v13122514 crossref_primary_10_1182_blood_2006_04_016634 crossref_primary_10_1016_j_semcancer_2020_03_016 crossref_primary_10_4292_wjgpt_v1_i3_75 crossref_primary_10_3390_biom10081118 crossref_primary_10_3892_or_2013_2414 crossref_primary_10_18632_oncotarget_4054 crossref_primary_10_3390_v14112352 crossref_primary_10_1073_pnas_0907070106 crossref_primary_10_1016_j_clim_2017_12_001 crossref_primary_10_1073_pnas_1211805110 crossref_primary_10_1038_labinvest_3700696 crossref_primary_10_1038_nm1659 crossref_primary_10_1158_2326_6066_CIR_15_0061 crossref_primary_10_1016_j_biopha_2022_113323 crossref_primary_10_1093_abbs_gmaa109 crossref_primary_10_1021_cb700186x crossref_primary_10_1002_jcb_24218 crossref_primary_10_18632_oncotarget_19932 crossref_primary_10_1016_j_canlet_2020_11_023 crossref_primary_10_1016_j_jhep_2014_03_017 crossref_primary_10_1182_blood_2005_08_007377 crossref_primary_10_3390_ijms25010331 crossref_primary_10_3390_ijms18061234 crossref_primary_10_1080_21623996_2014_999503 crossref_primary_10_1161_ATVBAHA_110_216200 crossref_primary_10_1038_ncomms10204 crossref_primary_10_1016_j_biocel_2017_10_002 crossref_primary_10_1158_0008_5472_CAN_07_6696 crossref_primary_10_1016_j_bbrc_2011_09_141 crossref_primary_10_1016_j_bbi_2014_04_008 crossref_primary_10_3892_or_2014_3098 crossref_primary_10_1002_stem_1746 crossref_primary_10_1172_JCI78488 crossref_primary_10_1007_s11523_012_0227_8 crossref_primary_10_3892_ijmm_2024_5379 crossref_primary_10_1016_j_bbrc_2014_01_086 crossref_primary_10_18632_oncotarget_23411 crossref_primary_10_1111_j_1471_4159_2008_05337_x crossref_primary_10_1016_j_ejmech_2016_10_028 crossref_primary_10_3390_cells9061451 crossref_primary_10_1371_journal_pone_0099391 crossref_primary_10_1038_srep31690 crossref_primary_10_1016_j_humpath_2006_09_012 crossref_primary_10_1053_j_semdp_2019_12_002 crossref_primary_10_1177_2040620712471553 crossref_primary_10_1016_j_bcp_2005_12_017 crossref_primary_10_1158_0008_5472_CAN_09_2655 crossref_primary_10_1007_s00018_019_03095_4 crossref_primary_10_1182_blood_2009_05_219584 crossref_primary_10_1186_s12935_023_02899_6 crossref_primary_10_24287_1726_1708_2024_23_1_180_191 crossref_primary_10_3390_cancers6031408 crossref_primary_10_1038_leu_2009_91 crossref_primary_10_1038_cddis_2016_305 crossref_primary_10_1002_path_2990 crossref_primary_10_1007_s11033_014_3242_2 crossref_primary_10_1111_acel_13773 crossref_primary_10_1016_j_ydbio_2012_04_034 crossref_primary_10_2217_epi_10_51 crossref_primary_10_1007_s12026_009_8134_5 crossref_primary_10_1038_nrc1837 crossref_primary_10_1186_s13046_016_0301_7 crossref_primary_10_1038_s41417_018_0057_7 crossref_primary_10_2147_JIR_S459263 crossref_primary_10_1158_0008_5472_CAN_20_2297 crossref_primary_10_1016_j_cca_2012_05_007 crossref_primary_10_1016_j_biocel_2019_02_006 crossref_primary_10_1016_j_clim_2009_05_019 crossref_primary_10_1002_advs_202200169 crossref_primary_10_1038_s41577_019_0232_6 crossref_primary_10_3390_cimb46030156 crossref_primary_10_1016_j_jid_2018_03_1526 crossref_primary_10_3390_cancers11121930 crossref_primary_10_7314_APJCP_2015_16_6_2219 crossref_primary_10_1038_sj_jid_5701246 crossref_primary_10_1089_dna_2013_2042 crossref_primary_10_1200_JCO_2010_31_8907 crossref_primary_10_1080_08916930802024616 crossref_primary_10_3390_ijms19092708 crossref_primary_10_1007_s00109_010_0640_3 crossref_primary_10_4049_jimmunol_182_1_259 crossref_primary_10_1016_j_biopha_2020_111077 crossref_primary_10_1016_j_jneuroim_2012_03_003 crossref_primary_10_1016_j_leukres_2008_08_014 crossref_primary_10_1128_MCB_00467_08 crossref_primary_10_1038_labinvest_3700394 crossref_primary_10_1080_2162402X_2017_1333215 crossref_primary_10_1007_s00432_021_03519_4 crossref_primary_10_1182_blood_2006_04_017434 crossref_primary_10_2217_epi_14_18 crossref_primary_10_1186_ar3309 crossref_primary_10_1093_nar_gkv508 crossref_primary_10_1186_s13148_023_01436_6 crossref_primary_10_1016_j_ejmech_2012_08_024 crossref_primary_10_1002_bdrc_20163 crossref_primary_10_1038_cddis_2013_18 crossref_primary_10_1096_fj_202000600RR crossref_primary_10_1182_blood_2006_11_058388 crossref_primary_10_3389_fimmu_2022_880315 crossref_primary_10_1517_14728222_10_1_157 crossref_primary_10_4161_jkst_22436 crossref_primary_10_3390_ijms222413571 crossref_primary_10_1210_en_2008_1142 crossref_primary_10_1016_j_abb_2022_109189 crossref_primary_10_3389_fimmu_2019_02634 crossref_primary_10_1007_s10620_012_2160_1 crossref_primary_10_1038_sj_leu_2404323 crossref_primary_10_1111_febs_16679 crossref_primary_10_3390_app11136192 crossref_primary_10_1093_hmg_dds403 crossref_primary_10_3390_ijms20092150 crossref_primary_10_1182_blood_2016_05_717793 crossref_primary_10_1111_febs_13285 crossref_primary_10_3390_cancers9080100 crossref_primary_10_1186_s12964_021_00747_6 crossref_primary_10_1007_s00109_005_0020_6 crossref_primary_10_1016_j_bbi_2019_01_013 crossref_primary_10_1128_MCB_05310_11 crossref_primary_10_4236_jct_2015_68078 crossref_primary_10_1007_s10875_013_9903_4 crossref_primary_10_1073_pnas_1100319108 |
Cites_doi | 10.1038/nrg816 10.4049/jimmunol.168.1.466 10.1038/nrd772 10.4049/jimmunol.171.2.616 10.1038/sj.onc.1205152 10.1074/jbc.M001748200 10.1073/pnas.94.13.6764 10.1016/S0002-9440(10)64629-9 10.1074/jbc.274.36.25343 10.1126/science.1071545 10.1073/pnas.93.17.9148 10.1158/1541-7786.62.2.1 10.1038/nrc1275 10.1128/JVI.77.11.6385-6393.2003 10.1074/jbc.M309096200 10.1128/MCB.20.1.389-401.2000 10.1158/1535-7163.261.3.3 10.1128/MCB.23.17.6291-6299.2003 10.1038/ng1068 10.1016/S1097-2765(01)00199-X 10.1038/sj.onc.1206814 10.1182/blood-2003-06-2007 10.1056/NEJMra023075 10.1074/jbc.M301578200 10.1038/sj.onc.1205609 10.1038/77124 10.1182/blood.V95.3.745.003k05_745_755 10.1093/annonc/mdg216 10.1101/gad.1123303 10.1126/science.1065173 |
ContentType | Journal Article |
Copyright | Copyright 1993/2005 The National Academy of Sciences of the United States of America Copyright National Academy of Sciences May 10, 2005 Copyright © 2005, The National Academy of Sciences 2005 |
Copyright_xml | – notice: Copyright 1993/2005 The National Academy of Sciences of the United States of America – notice: Copyright National Academy of Sciences May 10, 2005 – notice: Copyright © 2005, The National Academy of Sciences 2005 |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 7QG 7QL 7QP 7QR 7SN 7SS 7T5 7TK 7TM 7TO 7U9 8FD C1K FR3 H94 M7N P64 RC3 7X8 5PM |
DOI | 10.1073/pnas.0501959102 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef Animal Behavior Abstracts Bacteriology Abstracts (Microbiology B) Calcium & Calcified Tissue Abstracts Chemoreception Abstracts Ecology Abstracts Entomology Abstracts (Full archive) Immunology Abstracts Neurosciences Abstracts Nucleic Acids Abstracts Oncogenes and Growth Factors Abstracts Virology and AIDS Abstracts Technology Research Database Environmental Sciences and Pollution Management Engineering Research Database AIDS and Cancer Research Abstracts Algology Mycology and Protozoology Abstracts (Microbiology C) Biotechnology and BioEngineering Abstracts Genetics Abstracts MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef Virology and AIDS Abstracts Oncogenes and Growth Factors Abstracts Technology Research Database Nucleic Acids Abstracts Ecology Abstracts Neurosciences Abstracts Biotechnology and BioEngineering Abstracts Environmental Sciences and Pollution Management Entomology Abstracts Genetics Abstracts Animal Behavior Abstracts Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) AIDS and Cancer Research Abstracts Chemoreception Abstracts Immunology Abstracts Engineering Research Database Calcium & Calcified Tissue Abstracts MEDLINE - Academic |
DatabaseTitleList | MEDLINE CrossRef Virology and AIDS Abstracts AIDS and Cancer Research Abstracts MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Sciences (General) |
EISSN | 1091-6490 |
EndPage | 6953 |
ExternalDocumentID | 836473281 10_1073_pnas_0501959102 15870198 102_19_6948 3375461 |
Genre | Research Support, U.S. Gov't, P.H.S Journal Article Research Support, N.I.H., Extramural Feature |
GrantInformation_xml | – fundername: NCI NIH HHS grantid: R01 CA096856 – fundername: NCI NIH HHS grantid: R01 CA089194 – fundername: NCI NIH HHS grantid: R01 CA093371 – fundername: NCI NIH HHS grantid: R01-CA89194 – fundername: NCI NIH HHS grantid: R01-CA96856 – fundername: NCI NIH HHS grantid: P50-CA93371 |
GroupedDBID | --- -DZ -~X .55 .GJ 0R~ 123 29P 2AX 2FS 2WC 3O- 4.4 53G 5RE 5VS 79B 85S AACGO AAFWJ AANCE AAYJJ ABBHK ABOCM ABPLY ABPPZ ABTLG ABXSQ ABZEH ACGOD ACIWK ACNCT ACPRK ADULT ADZLD AENEX AEUPB AEXZC AFFNX AFOSN AFRAH ALMA_UNASSIGNED_HOLDINGS AQVQM ASUFR AS~ BKOMP CS3 D0L DCCCD DIK DNJUQ DOOOF DU5 DWIUU E3Z EBS EJD F20 F5P FRP GX1 HH5 HQ3 HTVGU HYE JAAYA JBMMH JENOY JHFFW JKQEH JLS JLXEF JPM JSG JSODD JST KQ8 L7B LU7 MVM N9A NEJ N~3 O9- OK1 P-O PNE PQQKQ R.V RHF RHI RNA RNS RPM RXW SA0 SJN TAE TN5 UKR VOH VQA W8F WH7 WHG WOQ WOW X7M XFK XSW Y6R YBH YKV YSK ZA5 ZCA ZCG ~02 ~KM - 02 0R 1AW 55 AAPBV ABFLS ABPTK ADACO AJYGW AS DZ GJ KM OHM PQEST X XHC ADACV CGR CUY CVF ECM EIF H13 IPSME NPM AAYXX CITATION 7QG 7QL 7QP 7QR 7SN 7SS 7T5 7TK 7TM 7TO 7U9 8FD C1K FR3 H94 M7N P64 RC3 7X8 5PM |
ID | FETCH-LOGICAL-c527t-9b31d441dab606945f29d658c697f821903b326104e3bd2d45bd11ca774043803 |
IEDL.DBID | RPM |
ISSN | 0027-8424 |
IngestDate | Tue Sep 17 21:26:06 EDT 2024 Sat Oct 26 05:59:26 EDT 2024 Fri Oct 25 07:31:17 EDT 2024 Thu Oct 10 17:10:21 EDT 2024 Fri Aug 23 00:57:27 EDT 2024 Sat Nov 02 12:28:57 EDT 2024 Wed Nov 11 00:29:19 EST 2020 Thu May 30 08:53:07 EDT 2019 Fri Feb 02 07:04:49 EST 2024 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 19 |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c527t-9b31d441dab606945f29d658c697f821903b326104e3bd2d45bd11ca774043803 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 ObjectType-Article-1 ObjectType-Feature-2 Communicated by Peter C. Nowell, University of Pennsylvania School of Medicine, Philadelphia, PA, March 9, 2005 To whom correspondence should be addressed. E-mail: wasik@mail.med.upenn.edu. Abbreviations: ALK+ TCL, T cell lymphoma expressing anaplastic lymphoma kinase; ChIP, chromatin immunoprecipitation; CTCL, cutaneous T-cell lymphoma; DNMT, DNA methyltransferase; HDAC, histone deacetylase; ON, oligonucleotide; PBMC; peripheral blood mononuclear cells; PHA-BL, phytohemagglutinin-activated T cell blasts; siRNA, small interfering RNA; STAT, signal transducer and activator of transcription. Author contributions: Q.Z. and M.A.W. designed research; Q.Z., H.Y.W., M.M., P.N.R., and T.N. performed research; and M.A.W. wrote the paper. |
OpenAccessLink | https://europepmc.org/articles/pmc1100783?pdf=render |
PMID | 15870198 |
PQID | 201379973 |
PQPubID | 42026 |
PageCount | 6 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_1100783 pubmed_primary_15870198 pnas_primary_102_19_6948_fulltext jstor_primary_3375461 proquest_miscellaneous_67821421 proquest_journals_201379973 proquest_miscellaneous_17622278 pnas_primary_102_19_6948 crossref_primary_10_1073_pnas_0501959102 |
ProviderPackageCode | RNA PNE |
PublicationCentury | 2000 |
PublicationDate | 2005-05-10 |
PublicationDateYYYYMMDD | 2005-05-10 |
PublicationDate_xml | – month: 05 year: 2005 text: 2005-05-10 day: 10 |
PublicationDecade | 2000 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: Washington |
PublicationTitle | Proceedings of the National Academy of Sciences - PNAS |
PublicationTitleAlternate | Proc Natl Acad Sci U S A |
PublicationYear | 2005 |
Publisher | National Academy of Sciences National Acad Sciences |
Publisher_xml | – name: National Academy of Sciences – name: National Acad Sciences |
References | e_1_3_2_26_2 e_1_3_2_27_2 e_1_3_2_28_2 e_1_3_2_29_2 e_1_3_2_20_2 e_1_3_2_21_2 e_1_3_2_22_2 (e_1_3_2_31_2) 2004; 3 e_1_3_2_23_2 e_1_3_2_24_2 e_1_3_2_25_2 (e_1_3_2_9_2) 2002; 306 (e_1_3_2_30_2) 2004; 2 e_1_3_2_15_2 e_1_3_2_8_2 e_1_3_2_16_2 e_1_3_2_7_2 e_1_3_2_17_2 e_1_3_2_6_2 e_1_3_2_18_2 e_1_3_2_19_2 e_1_3_2_1_2 e_1_3_2_32_2 e_1_3_2_10_2 (e_1_3_2_13_2) 2002; 62 e_1_3_2_5_2 e_1_3_2_11_2 e_1_3_2_4_2 e_1_3_2_12_2 e_1_3_2_3_2 e_1_3_2_2_2 e_1_3_2_14_2 |
References_xml | – ident: e_1_3_2_1_2 doi: 10.1038/nrg816 – ident: e_1_3_2_6_2 doi: 10.4049/jimmunol.168.1.466 – ident: e_1_3_2_29_2 doi: 10.1038/nrd772 – ident: e_1_3_2_24_2 doi: 10.4049/jimmunol.171.2.616 – ident: e_1_3_2_7_2 doi: 10.1038/sj.onc.1205152 – volume: 62 start-page: 6390 year: 2002 ident: e_1_3_2_13_2 publication-title: Cancer Res. – ident: e_1_3_2_16_2 doi: 10.1074/jbc.M001748200 – ident: e_1_3_2_5_2 doi: 10.1073/pnas.94.13.6764 – ident: e_1_3_2_12_2 doi: 10.1016/S0002-9440(10)64629-9 – ident: e_1_3_2_20_2 doi: 10.1074/jbc.274.36.25343 – ident: e_1_3_2_17_2 doi: 10.1126/science.1071545 – ident: e_1_3_2_4_2 doi: 10.1073/pnas.93.17.9148 – volume: 2 start-page: 62 year: 2004 ident: e_1_3_2_30_2 publication-title: Mol. Cancer Res. doi: 10.1158/1541-7786.62.2.1 – ident: e_1_3_2_8_2 doi: 10.1038/nrc1275 – ident: e_1_3_2_32_2 doi: 10.1128/JVI.77.11.6385-6393.2003 – ident: e_1_3_2_11_2 doi: 10.1074/jbc.M309096200 – ident: e_1_3_2_18_2 doi: 10.1128/MCB.20.1.389-401.2000 – volume: 3 start-page: 261 year: 2004 ident: e_1_3_2_31_2 publication-title: Mol. Cancer Ther. doi: 10.1158/1535-7163.261.3.3 – ident: e_1_3_2_10_2 doi: 10.1128/MCB.23.17.6291-6299.2003 – ident: e_1_3_2_21_2 doi: 10.1038/ng1068 – ident: e_1_3_2_23_2 doi: 10.1016/S1097-2765(01)00199-X – ident: e_1_3_2_28_2 doi: 10.1038/sj.onc.1206814 – ident: e_1_3_2_14_2 doi: 10.1182/blood-2003-06-2007 – ident: e_1_3_2_3_2 doi: 10.1056/NEJMra023075 – ident: e_1_3_2_25_2 doi: 10.1074/jbc.M301578200 – ident: e_1_3_2_2_2 doi: 10.1038/sj.onc.1205609 – volume: 306 start-page: 1 year: 2002 ident: e_1_3_2_9_2 publication-title: Gene. – ident: e_1_3_2_15_2 doi: 10.1038/77124 – ident: e_1_3_2_19_2 doi: 10.1182/blood.V95.3.745.003k05_745_755 – ident: e_1_3_2_22_2 doi: 10.1093/annonc/mdg216 – ident: e_1_3_2_26_2 doi: 10.1101/gad.1123303 – ident: e_1_3_2_27_2 doi: 10.1126/science.1065173 |
SSID | ssj0009580 |
Score | 2.3337157 |
Snippet | Expression of SHP-1 phosphatase, a key negative regulator of cell signaling, is lost in T cell lymphomas and other malignancies due to DNA methylation of the... |
SourceID | pubmedcentral proquest crossref pubmed pnas jstor |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 6948 |
SubjectTerms | Antibodies Base Sequence Binding sites Biological Sciences Blotting, Western Cell Line, Tumor Cell lines Chromatin Immunoprecipitation CpG Islands DNA DNA (Cytosine-5-)-Methyltransferase 1 DNA (Cytosine-5-)-Methyltransferases - metabolism DNA Methylation DNA Modification Methylases - metabolism DNA-Binding Proteins - metabolism Down-Regulation Enzymes Epigenetics Gene Silencing Genes Histone Deacetylase 1 Histone Deacetylases - metabolism Humans Immunohistochemistry Immunoprecipitation Intracellular Signaling Peptides and Proteins Lymphoma Lymphoma, T-Cell - metabolism Medical research Methylation Models, Genetic Molecular Sequence Data Polymerase chain reaction Promoter Regions, Genetic Protein Binding Protein Tyrosine Phosphatase, Non-Receptor Type 6 Protein Tyrosine Phosphatases - metabolism Reverse Transcriptase Polymerase Chain Reaction RNA, Messenger - metabolism RNA, Small Interfering - metabolism Signal transduction STAT3 Transcription Factor T cell lymphoma T lymphocytes T-Lymphocytes - enzymology T-Lymphocytes - immunology Trans-Activators - metabolism Transfection |
Title | STAT3- and DNA Methyltransferase 1-Mediated Epigenetic Silencing of SHP-1 Tyrosine Phosphatase Tumor Suppressor Gene in Malignant T Lymphocytes |
URI | https://www.jstor.org/stable/3375461 http://www.pnas.org/content/102/19/6948.abstract https://www.ncbi.nlm.nih.gov/pubmed/15870198 https://www.proquest.com/docview/201379973 https://search.proquest.com/docview/17622278 https://search.proquest.com/docview/67821421 https://pubmed.ncbi.nlm.nih.gov/PMC1100783 |
Volume | 102 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Nb9NAEB21PXFBFAo1hbJIHMphk6zXn8eoUAVQq0pNpd5WXu-aREpsq3YO-RX8ZWY2dkIQvXCztLPWWDOz81aeeQPwSYwK7ZtIcoPZgtN4bZ5arXlRJFZYYcLYDZu4vokm98H3h_DhAMK-F8YV7ed6PigXy0E5n7naynqZD_s6seHt9SXRnMWJHB7CITpof0XfMu0mm74TH4_fwA96Pp9YDusyawajkHrkMEu6QTZhQnzkyV5W2hQmEtspyv8Lef5dQPlHRrp6Ac87KMnGG5WP4cCWL-G4C9aGXXSM0p9fwa-76XgqOctKw77cjBmNjV4vWodZUaSxTHDXQoLwk9maCDqpt5E1c2pJwuTGqoLdTW65YO0aPwCRKatnVVPPspZ2t6tl9ciaVe2qavGRXsDmJVsiyv9JpTZsyhZrdJwqXyO2PYH7q6_TywnvJjHwPPTjlqdaCoPAyWQ6ok7ZsPBTg9glj9K4SPDQG0mNOBCvdlZq45sg1EaIPENs6Sjt5Ws4KqvSngIrsqCwOV5EZagDkQaZzRGBBQj7Yl_LyHpw0VtC1RvCDeV-lMdSkT3Uzn4enDhLbeUkzfONhAenTnK33VciVah34sHHp5ZU0VXbeHDWW1x1Ad0on6gZ0zSWHnzYrmIk0u-VrLTVqlEC8wo1Fj8tgcCAGO5QwTcb_9np0fmhB_GeZ20FiAV8fwWDw7GBd8Hw9r93nsEzx0frKGnfwVH7uLLvEWm1-hzvGN9-nLv4-g1wjCf3 |
link.rule.ids | 230,315,730,783,787,888,27936,27937,53804,53806 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3Pb9MwFH4a4wAXxmBsYcCMxGEcktZxfh6rwVRgrSYtQ7tZceLQijaJluTQ_RP8yzw7SUsndoBbJD9HTvzZ77P83vcAPtBhJuzUY2aK3sJU5bXNUAphZlkgqaSp6-tiE5OpN752vt64Nzvg9rkwOmg_EXMrXyytfD7TsZXlMhn0cWKDy8mZkjnzAzZ4BI9xvQ6d_pC-1toN2swTGzdgx3Z6RR-fDco8rqyhq7Lk0E_qUjZuoBTJgy2_1IYmKr1TtP8b97wfQvmHTzrfg-_917ShKD-tphZWcndP6PGfP_c5POtYKhm1zfuwI_MXsN_tAxU57cSqP76EX1fRKGImifOUfJqOiKpIvVrUmg6jSSUJNXV2CjJbIkul_anSJkk1V9lO6DdJkZGr8aVJSb3CP4Okl5Szoipnca16182yuCVVU-qAXXxULyDznCzxAPFDRfGQiCxWiMkiWSFtPoDr88_R2djsijyYiWv7tRkKRlPkZGksPJWE62Z2mCItSrzQzwLcT4dMIMXEU6NkIrVTxxUppUmMtFWr5bNXsJsXuTwCksVOJhM84zJXODR0YpkguXOQUfq2YJ404LSfYl62Wh5c38H7jKuJ5htgGHCgIbC2Y6pUsEcNONKWm-42pyHHcQcGvH-oiWddII8Bxz2UeLdXVNxWqo9h6DMDTtatuMjVzU2cy6KpOEWXpXKWH7ZAzqHE83CAhy0wN-PoAG6AvwXZtYESGN9uQSBqofEOeK__u-cJPBlHkwt-8WX67RieatlbrXz7Bnbr20a-RUJXi3d6-f4GxohI6A |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3Pb9MwFH6CISEuwGBsYcCMxGEc0tZxfh6rjar8WFVpnTRxseLYoRVtEi3JofwT_Ms8O0m7TuyyWyQ_R0782e-z_N73AD7RQSoc6TNborewdXltO1JC2GkaKqqo9AJTbOJi4o-v3G_X3vWtUl8maD8Ri162XPWyxdzEVharpN_FifWnF2da5iwIWb-Qaf8xPME1O_C7g_pGbzdssk8c3IRdx-1UfQLslcVlb-DpTDn0laacjRdqVfJwxzc14Yla8xTt_8c_74ZR3vJLoxfws_uiJhzld6-uRC_5c0fs8UGf_BKet2yVDBuTfXikslew3-4HJTltRas_v4a_l7PhjNkkziQ5nwyJrky9XlaGFqNJqQi1TZYKMlyiCq0BqtMnSbnQWU_oP0meksvx1KakWuPfQfJLinleFvO40r2repXfkLIuTOAuPuoXkEVGVniQ-KWjeciMLNeIzTxZI30-gKvRl9nZ2G6LPdiJ5wSVHQlGJXIzGQtfJ-N6qRNJpEeJHwVpiPvqgAmkmnh6VExIR7qekJQmMdJXo5rP3sBelmfqCEgau6lK8KzLPOHSyI1VgiTPRWYZOIL5yoLTbpp50Wh6cHMXHzCuJ5tvwWHBgYHBxo7pksE-teDIWG67O5xGHMcdWvDxviaetgE9Fhx3cOLtnlFyR6s_RlHALDjZtOJi1zc4cabyuuQUXZfOXb7fArmHFtHDAR424NyOowW5BcEObDcGWmh8twXBaATHW_C9fXDPE3g6PR_xH18n34_hmVG_NQK472CvuqnVe-R1lfhgVvA_BbJLaA |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=STAT3-+and+DNA+Methyltransferase+1-Mediated+Epigenetic+Silencing+of+SHP-1+Tyrosine+Phosphatase+Tumor+Suppressor+Gene+in+Malignant+T+Lymphocytes&rft.jtitle=Proceedings+of+the+National+Academy+of+Sciences+-+PNAS&rft.au=Zhang%2C+Qian&rft.au=Wang%2C+Hong+Y.&rft.au=Marzec%2C+Michal&rft.au=Raghunath%2C+Puthiyaveettil+N.&rft.date=2005-05-10&rft.pub=National+Academy+of+Sciences&rft.issn=0027-8424&rft.eissn=1091-6490&rft.volume=102&rft.issue=19&rft.spage=6948&rft.epage=6953&rft_id=info:doi/10.1073%2Fpnas.0501959102&rft.externalDocID=3375461 |
thumbnail_m | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fwww.pnas.org%2Fcontent%2F102%2F19.cover.gif |
thumbnail_s | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fwww.pnas.org%2Fcontent%2F102%2F19.cover.gif |